Abstract:Purpose: Lubricant eye drops are the main therapeutic resource for dry eye disease (DED), with each drop representing the equivalent of ocular surface disease treatment. Thus, any reduction in the frequency of eye drop application reflects a degree of therapeutic success. Considering also the socioeconomic burden of DED, we investigated eye drop application frequency (DF) as a parameter to potentially track the success of therapy in severe DED. Hyaluronan (HA)-containing eye drops have become the first choice for tear substitution in many countries, and recent data indicate that the average molecular weight (Mw) of HA determines the therapeutic efficacy of such eye drops. This post-hoc subgroup analysis of a previously published multicentre prospective randomized open-label study, HYLAN M, is set out to compare the effects of very high Mw HA (hylan A) eye drops to comparator eye drops, containing lower Mw HA (control). Methods: Patients with severe DED (n = 47), recruited as part of the larger HYLAN M prospective, multicentre, open-label study, were randomized into two groups: hylan A and control group. In the hylan A group, 24 patients replaced their HA-containing eye drops with eye drops containing 0.15% hylan A, whereas the 23 control patients continued to use comparator HA eye drops. The DF was recorded daily by all participants over 8 weeks, and other subjective and objective parameters of DED were assessed at the time of inclusion (baseline), as well as at week 4 and 8. Results: There was a significant decrease in DF in the hylan A users between the baseline and week 4 (p = 0.004), remaining stable until week 8. Indeed, in contrast to the baseline, the hylan A group had a significantly lower DF than the control group at weeks 4 (p = 0.018) and 8 (p = 0.008). Likewise, the ocular surface disease index (OSDI) improved significantly between the time of inclusion and week 4 (p < 0.001) in hylan A users, remaining stable until week 8. The OSDI was similar in both groups at the baseline but it was significantly lower in the hylan A group than in the control group at week 4 (p = 0.002), remaining lower at week 8. Such a decrease in the DF and OSDI was not witnessed in the control group at any time point. The objective parameters assessed did not differ significantly within or between the two groups. Conclusion: When treating severe DED, the DF can be significantly reduced by using very high Mw HA (3 MDa) lubricant eye drops, which better alleviate DED symptoms and decrease the OSDI scores. These drops not only provide an attractive and comfortable alternative for patients with severe DED but also offer the possibility of reducing the disease's socioeconomic burden, both for affected individuals and society as a whole.

The use of artificial tears among the danish population: Epidemiological observations

Closing Eyes with Artificial Tears: A Simple and Effective Strategy to Combat Screen-Related Asthenopia and Dry Eye Symptoms

Evaluating the Efficacy of the Diluted Schirmer Method for Tear Collection in Dry Eye Syndrome Patients

Artificial tears, preservatives, so what?

Ophthalmic quality of life in the adult Danish population: an epidemiological study

The Short-term Effects of Artificial Tears on the Tear Film Assessed by a Novel High-Resolution Tear Film Imager: A Pilot Study

Effect of Artificial Tears on Preoperative Keratometry and Refractive Precision in Cataract Surgery

Higher occurrence of ocular surface disease symptoms in patients with atopic dermatitis—Data in the FOREVER study

Prevailing practices for the management of dry eye disease in India: A questionnaire based survey 2023

Heterogeneity of eye drop use among symptomatic dry eye individuals in Japan: large-scale crowdsourced research using DryEyeRhythm application

Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis

Application frequency - key indicator for the efficiency of severe dry eye disease treatment - evidence for the importance of molecular weight of hyaluronan in lubricating agents

Response predictors of a topical corticosteroid‐based regimen for dry eyes: A real‐life study

Autologous serum eye drops for patients with dry eye disease: a systematic review and meta-analysis of randomized controlled trials

Expert opinion in the management of aqueous Deficient Dry Eye Disease (DED)

Behind blue eyes – Ocular nutritional supplements on the Scandinavian market in relation to current evidence

The Danish Rural Eye Study: prevalence of strabismus among 3785 Danish adults - a population-based cross-sectional study

The Association of Dry Eye Disease with Functional Visual Acuity and Quality of Life

Estimates of dry eye disease in Saudi Arabia based on a short questionnaire of prevalence, symptoms, and risk factors: The Twaiq Mountain Eye Study I

Ocular surface and tear film status among contact lens wearers and non-wearers who use VDT at work: comparing three different lens types